Clinical Trial Update: Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy of products against biological effects induced by long-wavelength UVA1 and visible light on sun-damaged skin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sun-damaged Skin

Snippet

Sponsor: Henry Ford Health System | Conditions: Sun Damaged Skin | Phase 2 | Status: ACTIVE_NOT_RECRUITING